RxDoctor Payments Data

Mary Veremis Ley, DO

Dermatology · Clinton Township, MINPI 1235133703

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,169 of the $5,796 with a category attached, or 71.9%. 28 manufacturers reported payments, led by LEO Pharma Inc. at 25.3% of the total.

$5,796in general payments, 2019–2025

Across 143 payments — averaging $40.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • LEO Pharma Inc.$1K
  • AbbVie$978
  • Sanofi$602
  • UCB, Inc.$593
  • Johnson & Johnson$395
  • Regeneron Healthcare Solutions, Inc.$334
  • plus $1K from 22 others
$331,074in research payments, 2019–2025

Across 45 payments — averaging $7357.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$324K
  • Eli Lilly$7K
  • E.r. Squibb & Sons, L.L.C.$61

What the payments were for

  • Consulting fees$1,24021%
  • Travel & lodging$631%
  • Food & beverage$4,16972%
  • Education$3256%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,796 in reported general payments places this provider in the 65th percentile of 404 dermatology providers in Michigan.

See all dermatology providers in Michigan

Medicare billing

Part B allowed, 2024
$243,278
Medicare patients
743
Services billed
3,752

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil104$6,780
Clobetasol Propionate145$3,956
Azelaic Acid24$2,170
Econazole Nitrate88$2,131
Hydrocortisone108$1,845
Tretinoin21$1,834
Metronidazole50$1,597
Clindamycin Phosphate59$1,431
Mupirocin193$1,215
Fluticasone Propionate86$1,179
Triamcinolone Acetonide106$1,046
Doxycycline Hyclate65$996
Ketoconazole60$892
ValacyclovirValacyclovir Hcl30$704
Dutasteride16$638

Paid to pharmacies, not to this prescriber.

Other dermatology in Clinton Township

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →